+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites

Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites

Protein Engineering 10(2): 109-117

Neuropeptide Y (NPY) receptors belong to the G-protein-coupled receptor (GPCR) superfamily and mediate several physiological responses, such as blood pressure, food intake, sedation and memory retention. To understand the interactions between the NPY Y1 receptor subtype and its ligands, computer modeling was applied to the natural peptide agonist, NPY and a small molecule antagonist, BIBP3226. An agonist and antagonist binding domain was elucidated using mutagenesis data for the Y1 receptor as well as for other GPCR families. The agonist and antagonist ligands which were investigated appear to share common residues for their interaction within the transmembrane regions of the Y1 receptor structure, including Gln120, Asn283 and His306. This is in contrast to findings with tachykinin receptors where the binding domains of the non-peptide antagonists have very little in common with the binding domains of the agonist, substance-P. In addition, a hydrogen bond between the hydroxyl group of Tyr36 of NPY and the side chain of Gln219, an interaction that is absent in the model complex between Y1 and the antagonist BIBP3226, is proposed as one of the potential interactions necessary for receptor activation.

(PDF emailed within 0-6 h: $19.90)

Accession: 009031265

Download citation: RISBibTeXText

PMID: 9089810

DOI: 10.1093/protein/10.2.109

Related references

Agonist and antagonist binding to G-protein-coupled B2 kinin receptor. FASEB Journal 8(4-5): A352, 1994

Human P2Y1 receptor Molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist binding sites. Drug Development Research 43(1): 32, 1998

Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptor. Chemistry & Biology 1(4): 211-221, 1994

The affinity ratio for antagonist and agonist labeled binding sites predicts muscarinic receptor agonist antagonist action in central and peripheral tissues. Society for Neuroscience Abstracts 13(1): 487, 1987

Useful pharmacological parameters for G-protein-coupled receptor homodimers obtained from competition experiments. Agonist-antagonist binding modulation. Biochemical Pharmacology 78(12): 1456-1463, 2009

Characterization of G protein and phospholipase C-coupled agonist binding to the Y1 neuropeptide Y receptor in rat brain: sensitivity to G protein activators and inhibitors and to inhibitors of phospholipase C. Journal of Pharmacology and Experimental Therapeutics 286(1): 382-391, 1998

G Protein-Coupled Estrogen Receptor (GPER) Agonist Dual Binding Mode Analyses toward Understanding of its Activation Mechanism: A Comparative Homology Modeling Approach. Molecular Informatics 32(7): 647-658, 2013

Toward an understanding of agonist binding to human Orexin-1 and Orexin-2 receptors with G-protein-coupled receptor modeling and site-directed mutagenesis. Biochemistry 52(46): 8246-8260, 2014

Novel computational methodologies for structural modeling of spacious ligand binding sites of G-protein-coupled receptors: development and application to human leukotriene B4 receptor. Thescientificworldjournal 2012: 691579-691579, 2013

Definition of the agonist and antagonist binding sites on the bradykinin receptor. Abstracts of Papers American Chemical Society 206(1-2): MEDI 261, 1993

Distinct agonist- and antagonist-binding sites on the glycine receptor. Neuron 9(3): 491-496, 1992

Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor. Journal of Biological Chemistry 271(49): 31593-31601, 1996

A model of non-exclusive binding of agonist and antagonist on G-protein coupled receptors. Journal of Theoretical Biology 175(4): 577-582, 1995

A model of the serotonin 5-HT1A receptor: agonist and antagonist binding sites. Drug Design and Discovery 11(3): 231-249, 1994

A model of the adrenergic beta-2 receptor and binding sites for agonist and antagonist. Drug Design and Discovery 9(1): 29-48, 1992